General Information of Drug (ID: DMRZK9A)

Drug Name
2-nitro-N-(2,4,5-trichlorophenyl)benzamide
Synonyms
2-nitro-N-(2,4,5-trichlorophenyl)benzamide; CHEMBL570080; AC1LEFM1; CBMicro_048760; Oprea1_298416; MolPort-001-513-202; ZINC103157; STL255954; BDBM50297534; AKOS003265549; MCULE-2760222088; ST011169; BIM-0048873.P001
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 345.6
Logarithm of the Partition Coefficient (xlogp) 4.5
Rotatable Bond Count (rotbonds) 2
Hydrogen Bond Donor Count (hbonddonor) 1
Hydrogen Bond Acceptor Count (hbondacc) 3
Chemical Identifiers
Formula
C13H7Cl3N2O3
IUPAC Name
2-nitro-N-(2,4,5-trichlorophenyl)benzamide
Canonical SMILES
C1=CC=C(C(=C1)C(=O)NC2=CC(=C(C=C2Cl)Cl)Cl)[N+](=O)[O-]
InChI
InChI=1S/C13H7Cl3N2O3/c14-8-5-10(16)11(6-9(8)15)17-13(19)7-3-1-2-4-12(7)18(20)21/h1-6H,(H,17,19)
InChIKey
IWLWJYOQIYGDKH-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
711434
TTD ID
D07UTV

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Bacterial Fatty acid synthetase I (Bact inhA) TTVTX4N INHA_MYCTU Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Discovery of potential new InhA direct inhibitors based on pharmacophore and 3D-QSAR analysis followed by in silico screening. Eur J Med Chem. 2009 Sep;44(9):3718-30.